Organigram Global (OGI) Cash from Financing Activities (2018 - 2026)
Organigram Global (OGI) reported Cash from Financing Activities of -$657014.3 for Q1 2026, down 102.32% year-over-year from $28.3 million in Q1 2025, and down 103.61% quarter-over-quarter from -$322688.8 in Q4 2025.
Organigram Global (OGI) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Cash from Financing Activities data on file, last reported at -$657014.3 in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$657014.3, down 102.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.2 million (up 100.06% YoY), and the FY2025 annual result was $28.6 million, down 63.93% from the prior year.
- Cash from Financing Activities slipped to -$657014.3 in Q1 2026 per OGI's latest filing, from -$322688.8 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $28.3 million in Q1 2025 and troughed at -$657014.3 in Q1 2026.
- A 3-year average of $6.8 million and a median of -$233645.2 in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities plunged 123.16% in 2025, then plunged 102.32% in 2026.
- A 3-year view of Cash from Financing Activities shows it stood at -$144601.5 in 2024, then sank by 123.16% to -$322688.8 in 2025, then slumped by 103.61% to -$657014.3 in 2026.
- Business Quant data shows OGI's Cash from Financing Activities at -$657014.3 in Q1 2026, -$322688.8 in Q4 2025, and $28.3 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | -657,014.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -657,014.33 |
| Mar 31, 2026 | -657,014.33 |
| Dec 31, 2025 | -322,688.83 |
| Dec 31, 2025 | -322,688.83 |
| Mar 31, 2025 | 28.34 Mn |
| Mar 31, 2025 | 28.34 Mn |
| Dec 31, 2024 | -144,601.53 |
| Dec 31, 2024 | -144,601.53 |
| May 31, 2021 | 161.93 Mn |
| May 31, 2021 | 161.93 Mn |
| Feb 28, 2021 | -42.78 Bn |
| Feb 28, 2021 | -42.78 Bn |
| Nov 30, 2020 | 63.19 Mn |
| Nov 30, 2020 | 63.19 Mn |
| Aug 31, 2020 | 34.29 Mn |
| Aug 31, 2020 | 34.29 Mn |
| May 31, 2020 | 3,555.00 |
| May 31, 2020 | 3,555.00 |
| Feb 29, 2020 | 86.61 Mn |
| Feb 29, 2020 | 86.61 Mn |